Skip to main content
Clinical Trials/NCT00286364
NCT00286364
Completed
Phase 4

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Rigshospitalet, Denmark1 site in 1 countryFebruary 3, 2006

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Infertility
Sponsor
Rigshospitalet, Denmark
Locations
1
Status
Completed
Last Updated
19 years ago

Overview

Brief Summary

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

Registry
clinicaltrials.gov
Start Date
February 3, 2006
End Date
TBD
Last Updated
19 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Indication and wish for IVF/ICSI treatment
  • Womens age 20-39 years (both inclusive)
  • Regular menstrual cycle within normal range
  • Body Mass Index: 18-30 kg/m2 (both inclusive)
  • Negative pregnancy test before treatment
  • A maximum of 3 earlier IVF/ICSI treatments that did not result in pregnancy

Exclusion Criteria

  • serious systemic disease
  • Presence of polycystic ovarian syndrome (PCOS)
  • Earlier poor response with less than 4 mature follicles
  • Earlier participation in the investigation

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials